PodcastIntel
Sign in Get Started Free
Science, Spoken
Science, Spoken

A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

Nov 30, 2023 · 9m
✨ AI Summary
  • CAR-T cell therapy faces cancer risk investigation.
  • The FDA is examining potential secondary cancer development.
  • Cutting-edge cancer treatments are under scrutiny for safety.

More from Science, Spoken

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Science, Spoken and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →